and Human Services (HHS)
EXPIRED
Participating Organization(s) |
National Institutes of Health (NIH) |
National Institute on Minority Health and Health Disparities (NIMHD) |
|
Funding Opportunity Title |
NIMHD Resource-Related Minority Health and Health Disparities Research (U24) |
Activity Code |
U24 Resource-Related Research Projects Cooperative Agreements |
Announcement Type |
New |
Related Notices |
|
Funding Opportunity Announcement (FOA) Number |
RFA-MD-11-005 |
Companion FOA |
None |
Only one application per institution is allowed, as defined in Section III. 3. Additional Information on Eligibility. |
|
Catalog of Federal Domestic Assistance (CFDA) Number(s) |
93.307 |
FOA Purpose |
This funding opportunity announcement (FOA) encourages applications from organizations to provide support for conducting minority health and health disparities resource-related research activities that support the objectives and research strategy outlined in the NIMHD FY 2009-2013 Health Disparities Strategic Plan. The priority areas for this initiative are: Bioethics Research, Global Health Research, Data Infrastructure and Dissemination, and Healthcare for Rural Populations Research. |
Posted Date |
April 5, 2011 |
Letter of Intent Due Date |
May 8, 2011 |
Application Due Date(s) |
June 8, 2011 |
AIDS Application Due Date(s) |
Not Applicable |
Scientific Merit Review |
July, 2011 |
Advisory Council Review |
August, 2011 |
Earliest Start Date(s) |
September, 2011 |
Expiration Date |
June 9, 2011 |
Due Dates for E.O. 12372 |
Not Applicable |
Required Application Instructions
It is critical that applicants follow the instructions in the PHS398 Application Guide except where instructed to do otherwise (in this FOA or in a Notice from the NIH Guide for Grants and Contracts). Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. While some links are provided, applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.
Part 1. Overview Information
Part 2. Full Text of Announcement
Section I. Funding Opportunity Description
Section II. Award Information
Section III. Eligibility Information
Section IV. Application and Submission
Information
Section V. Application Review Information
Section VI. Award Administration Information
Section VII. Agency Contacts
Section VIII. Other Information
Through this Funding Opportunity Announcement (FOA), the NIMHD invites cooperative agreement program (U24) applications for the purpose of conducting minority health and health disparities resource-related research activities that support the priority goals, objectives and research strategy outlined in the NIMHD FY 2009 - 2013 Health Disparities Strategic Plan. The strategic plan is divided in the four goal areas of: (a) Research, (b) Research Infrastructure/Capacity Building, (c) Outreach Dissemination and (d) Integration of Research, Research Infrastructure/Capacity-Building and Outreach Dissemination.
The areas of research emphasis outlined below reflect the priority areas from recommendations that were generated as a result of the 2008 Trans-NIH Summit on the Science of Eliminating Health Disparities. Additional information on the summit recommendations have been published in the April 2010 American Journal of Public Health supplement [Dankwa-Mullan et. al., Am J Public Health 2010 100: S12-S18]. The supplemental data outlining the recommendations can be found online at: http://ajph.aphapublications.org/cgi/content/abstract/100/S1/S12
Overall, the resource-related research funded through this mechanism is intended to embrace strategic partnerships and collaboration with other agencies, researchers, communities, health planners, policy experts, and other public and private groups to encourage greater coordination, investment, and national focus on health disparities research. Effective partnership models are important for creating sustainable health disparities outreach and dissemination efforts. An applicant's submission must focus on only one of the following core areas listed below:
a) Bioethics Research Infrastructure Initiative. This initiative is designed to develop and implement programs that foster greater participation of racial and ethnic minority populations in clinical trials. A similar effort was funded under the American Recovery and Reinvestment Act of 2009 that established nationally-recognized bioethics centers in the United States. Academic and other private, non-profit entities with a history of research and training engagement with health disparity communities are well suited for such an initiative. Specific aims of this initiative to develop and implement a comprehensive effort designed to enhance clinical trials recruitment and retention in the United States may include, but are not limited to:
Applications that involve assessment of the impact of project activities on actual minority enrollment in existing clinical trials and/or patient registries are strongly encouraged.
b) Global Health Research Initiative. This initiative is designed to foster a greater understanding of U.S. health disparities through projects that will enhance the resources or infrastructure for furthering global health disparities research. Certain populations abroad share similarities with U.S. groups by virtue of their ancestry, health practices, lifestyles, and/or other features. The health disparities present in many populations are strikingly similar to those in U.S. populations with respect to cardiovascular disease, cancer, diabetes, HIV/AIDS, and other prevalent diseases/conditions. Health disparities in the Caribbean region are of particular interest. As it has become more evident that many of the issues related to health disparities in the U.S. are intrinsically related to issues that also exist in other countries, it has become increasingly clear that there is much to learn in both directions, and much to share for the benefit of all.
As the world becomes an increasingly global community, there is a need for new, integrated, and multidimensional approaches to global health. The U.S. "traditional strength in the global health field is its capacity to generate knowledge" according to the Institute of Medicine’s 2009 report on The U.S. Commitment to Global Health: Recommendations for the New Administration
(http://www.nap.edu/catalog/12506.html). For this reason, advances made through international research studies stand to benefit both U.S. and other populations of the world. Such research could lead to effective and culturally relevant education strategies; development of novel diagnostics, drugs or other intervention technologies; or could contribute to identification of new avenues of research that would ultimately lead to health care interventions.
c) Data Infrastructure and Information Dissemination on Health Disparities Research Initiative. This initiative is designed to support the development of a National Health Disparities Research Coordinating Center (NHDRCC) to enhance information dissemination on health disparities research. The NHDRCC would collect, store, integrate, and track data on health disparities research; as well as analyze and interpret data from a variety of research projects to facilitate reporting on progress and gaps in health disparities research, and approaches to understanding health disparities.
The NIMHD will work with the NHDRCC to help provide overall coordination and facilitate dissemination of the data. The NHDRCC will develop a system with an informatics tool to search health disparities research data by several methods, including but not limited to geography, priority populations, principal investigators, diseases/conditions, determinants of health, research process (e.g. translational, transdisciplinary, etc.) and goals/objectives of the NIH Health Disparities Strategic Plan. The NHDRCC will establish a national infrastructure that is scalable and can be later expanded to include, but not be limited to: 1) disease incidence and prevalence, 2) trends across multiple disease risk factors, 3) health outcomes, and 4) subpopulation health status. The NHDRCC should explore novel approaches and technologies for data management, data mining, and data sharing across health disparities research data types and platforms. Access to information related to health disparities research for researchers, policy makers, health care providers, and the public is a fundamental aim of the initiative.
d) Healthcare for Rural Populations Research Initiative. This initiative is designed to enhance the resources or infrastructure for furthering health services research projects in the United States that will increase access to and improve the quality of healthcare for rural populations. In July 2009, NIMHD in partnership with the Health Resources and Services Administration convened a workshop of experts in rural health. The proceedings entitled, Research Gaps, Innovation and Best Practices to Address and Eliminate Rural Health Disparities provided a set of recommendations to improve the health of rural populations. For this FOA, priority topic areas for projects include: 1) information and communications technologies to increase access to care, 2) policies or initiatives to increase the supply of rural healthcare practitioners and/or the use of paraprofessionals or peer-led health services to supplement existing healthcare services, 3) strategies to organize, manage, finance, and deliver high quality care, and 4) translational and transdisciplinary research linking the social determinants of health and health disparities that is innovative, rigorous and well grounded in appropriate theoretical framework. Projects should focus on improving healthcare for all individuals belonging to the target population within a local or regional catchment area of specific health care services or systems rather than for individuals with a particular health disease/condition (e.g., adults with type 2 diabetes living in rural areas). Applicants should have demonstrated partnerships with healthcare organizations, local or state governments, professional provider organizations, patient/consumer advocacy groups, or other relevant collaborators to ensure the feasibility and eventual impact of projects.
Funding Instrument |
Cooperative Agreement: A support mechanism used when there will be substantial Federal scientific or programmatic involvement. Substantial involvement means that, after award, scientific or program staff will assist, guide, coordinate, or participate in project activities. |
Application Types Allowed |
New The OER Glossary and the PHS398 Application Guide provide details on these application types. |
Funds Available and Anticipated Number of Awards |
NIMHD intends to commit $6 million in FY 2011 and up to six awards. |
Award Budget |
Application direct costs are limited to $750,000 annually. Facilities and Administrative (F&A) costs requested by consortium participants are not included in the direct cost limitations. See NOT-OD-05-004.. |
Award Project Period |
Scope of the proposed project should determine the project period. The maximum period is 5 years. |
NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made in response to this FOA.
Higher Education Institutions:
The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
Nonprofits Other Than Institutions of Higher Education
For profit Organizations
Governments
Other
Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Foreign (non-U.S.) components of U.S. Organizations are allowed.
Applicant organizations must complete the following registrations as described in the PHS398 Application Guide to be eligible to apply for or receive an award. Applicants must have a valid Dun and Bradstreet Universal Numbering System (DUNS) number in order to begin each of the following registrations.
All Program Directors/Principal Investigators (PD/PIs) must also work with their institutional officials to register with the eRA Commons or ensure their existing eRA Commons account is affiliated with the eRA Commons account of the applicant organization.
All registrations must be completed by the application due date. Applicant organizations are strongly encouraged to start the registration process at least four (4) weeks prior to the application due date.
Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director/Principal Investigator (PD/PI) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the PHS398 Application Guide.
This FOA does not require cost sharing as defined in the NIH Grants Policy Statement.
Only one application will be accepted per applicant organization. For institutions of higher education, separate institutions for purposes of this FOA are entities governed by different Chancellors or Presidents.
NIH will not accept any application in response to this FOA that is essentially the same as one currently pending initial peer review unless the applicant withdraws the pending application. NIH will not accept any application that is essentially the same as one already reviewed.
Eligibility is limited for applicants applying under category (b) Data Infrastructure and Information Dissemination on Health Disparities Research Initiative. An independent non-NIMHD affiliated organization is required to ensure the confidentiality and integrity of data collected and analyzed.
Applicants are required to prepare applications according to the current PHS 398 application forms in accordance with the PHS 398 Application Guide.
It is critical that applicants follow the instructions in the PHS398 Application Guide, except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.
By the date listed in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:
Descriptive title of proposed research
Name, address, and telephone number of the PD(s)/PI(s)
Names of other key personnel
Participating institutions
Number and title of this funding opportunity
The letter of intent should be sent to:
Robert Nettey, MD
Chief, Office of Review
Division of Extramural Activities and Scientific Programs
National Institute on Minority Health & Health Disparities
6707 Democracy Blvd., Suite 800, MSC 5465
Bethesda, MD 20892-5465
Telephone: (301) 496-3996
Fax: (301) 480-4049
Email: [email protected]
Applications must be prepared using the PHS 398 research
grant application forms and instructions for preparing a research grant
application. Submit a signed, typewritten original of the application,
including the checklist, and three signed photocopies in one package to:
Center for Scientific Review
National Institutes of Health
6701 Rockledge Drive, Room 1040, MSC 7710
Bethesda, MD 20892-7710 (U.S. Postal Service Express or regular mail)
Bethesda, MD 20817 (for express/courier service; non-USPS service)
At the time of submission, two additional paper copies of
the application and all copies of the appendix files must be sent to:
Robert Nettey, MD
Chief, Office of Scientific Review
Division of Extramural Activities and Scientific Programs
National Institute on Minority Health & Health Disparities
6707 Democracy Blvd., Suite 800, MSC 5465
Bethesda, MD 20892-5465
Telephone: (301) 496-3996
Fax: (301) 480-4049
Email: [email protected]
All page limitations described in the PHS398 Application Guide must be followed, with the following exceptions or additional requirements:
All instructions in the PHS398 Application Guide must be followed, with the following additional instructions:
Resource Sharing Plan
Individuals are required to comply with the instructions for the Resource Sharing Plans (Data Sharing Plan, Sharing Model Organisms, and Genome Wide Association Studies (GWAS) as provided in the PHS398 Application Guide.,
Appendix
Do not use the appendix to circumvent page limits. Follow all instructions for the Appendix (please note all format requirements) as described in the PHS398 Application Guide.
Part I. Overview Information contains information about Key Dates.
Information on the process of receipt and determining if
your application is considered on-time is described in detail in the PHS398
Application Guide.
Applicants may track the status of the application in the eRA Commons, NIH’s electronic system for grants
administration.
This initiative is not subject to intergovernmental review.
All NIH awards are subject to the terms and conditions, cost
principles, and other considerations described in the NIH Grants Policy
Statement.
Pre-award costs are allowable only as described in the NIH Grants
Policy Statement.
Applications must be received on or before the due dates in Part I. Overview Information. If an
application is received after that date, it will not be reviewed.
Upon receipt, applications will be evaluated for completeness by the Center for Scientific Review and responsiveness by the NIMHD, NIH. Applications that are incomplete and/or nonresponsive will not be reviewed.
The annual budget must include funds for travel by the PD/PI(s) to participate in a required meeting in the United States, at a location to be determined by NIMHD staff.
Applicants are required to follow the instructions for post-submission materials, as described in NOT-OD-10-115.,
Only the review criteria described below will be considered
in the review process. As part of the NIH mission,
all applications submitted to the NIH in support of biomedical and behavioral
research are evaluated for scientific and technical merit through the NIH peer
review system.
Reviewers will provide an overall impact/priority score to reflect their assessment of the likelihood for the project to exert a sustained, powerful influence on the research field(s) involved, in consideration of the following review criteria and additional review criteria (as applicable for the project proposed).
Reviewers will consider each of the review criteria below in the determination of scientific merit, and give a separate score for each. An application does not need to be strong in all categories to be judged likely to have major scientific impact. For example, a project that by its nature is not innovative may be essential to advance a field.
Significance
Does the project address an important problem or a critical barrier to progress in the field? If the aims of the project are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved? How will successful completion of the aims change the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field?
Investigator(s)
Are the PD/PIs, collaborators, and other researchers well suited to the project? If Early Stage Investigators or New Investigators, or in the early stages of independent careers, do they have appropriate experience and training? If established, have they demonstrated an ongoing record of accomplishments that have advanced their field(s)? If the project is collaborative or multi-PD/PI, do the investigators have complementary and integrated expertise; are their leadership approach, governance and organizational structure appropriate for the project?
Innovation
Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation, or interventions? Are the concepts, approaches or methodologies, instrumentation, or interventions novel to one field of research or novel in a broad sense? Is a refinement, improvement, or new application of theoretical concepts, approaches or methodologies, instrumentation, or interventions proposed?
Approach
Are the overall strategy, methodology, and analyses
well-reasoned and appropriate to accomplish the specific aims of the project? Are potential problems, alternative strategies, and benchmarks for success presented?
If the project is in the early stages of development, will the strategy
establish feasibility and will particularly risky aspects be managed?
If the project involves clinical research, are the plans for 1) protection of
human subjects from research risks, and 2) inclusion of minorities and members
of both sexes/genders, as well as the inclusion of children, justified in terms
of the scientific goals and research strategy proposed?
Environment
Will the scientific environment in which the work will be done contribute to the probability of success? Are the institutional support, equipment and other physical resources available to the investigators adequate for the project proposed? Will the project benefit from unique features of the scientific environment, subject populations, or collaborative arrangements?
As applicable for the project proposed, reviewers will evaluate the following additional items while determining scientific and technical merit, and in providing an overall impact/priority score, but will not give separate scores for these items.
Protections for Human Subjects
For research that involves human subjects but does
not involve one of the six categories of research that are exempt under 45 CFR
Part 46, the committee will evaluate the justification for involvement of human
subjects and the proposed protections from research risk relating to their
participation according to the following five review criteria: 1) risk to
subjects, 2) adequacy of protection against risks, 3) potential benefits to the
subjects and others, 4) importance of the knowledge to be gained, and 5) data
and safety monitoring for clinical trials.
For research that involves human subjects and meets the criteria for one or
more of the six categories of research that are exempt under 45 CFR Part 46,
the committee will evaluate: 1) the justification for the exemption, 2) human
subjects involvement and characteristics, and 3) sources of materials. For
additional information on review of the Human Subjects section, please refer to
the Human
Subjects Protection and Inclusion Guidelines.
Inclusion of Women, Minorities, and Children
When the proposed project involves clinical research, the committee will evaluate the proposed plans for inclusion of minorities and members of both genders, as well as the inclusion of children. For additional information on review of the Inclusion section, please refer to the Human Subjects Protection and Inclusion Guidelines.
Vertebrate Animals
The committee will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following five points: 1) proposed use of the animals, and species, strains, ages, sex, and numbers to be used; 2) justifications for the use of animals and for the appropriateness of the species and numbers proposed; 3) adequacy of veterinary care; 4) procedures for limiting discomfort, distress, pain and injury to that which is unavoidable in the conduct of scientifically sound research including the use of analgesic, anesthetic, and tranquilizing drugs and/or comfortable restraining devices; and 5) methods of euthanasia and reason for selection if not consistent with the AVMA Guidelines on Euthanasia. For additional information on review of the Vertebrate Animals section, please refer to the Worksheet for Review of the Vertebrate Animal Section.
Biohazards
Reviewers will assess whether materials or procedures proposed are potentially hazardous to research personnel and/or the environment, and if needed, determine whether adequate protection is proposed.
Resubmissions
Not Applicable
Renewals
Not Applicable
Revisions
Not Applicable
As applicable for the project proposed, reviewers will consider each of the following items, but will not give scores for these items, and should not consider them in providing an overall impact/priority score.
Applications from Foreign Organizations
Not Applicable
Select Agent Research
Reviewers will assess the information provided in this section of the application, including 1) the Select Agent(s) to be used in the proposed research, 2) the registration status of all entities where Select Agent(s) will be used, 3) the procedures that will be used to monitor possession use and transfer of Select Agent(s), and 4) plans for appropriate biosafety, biocontainment, and security of the Select Agent(s).
Resource Sharing Plans
Reviewers will comment on whether the following Resource Sharing Plans, or the rationale for not sharing the following types of resources, are reasonable: 1) Data Sharing Plan; 2) Sharing Model Organisms; and 3) Genome Wide Association Studies (GWAS).
Budget and Period of Support
Reviewers will consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research.
Applications will be evaluated for scientific and technical
merit by (an) appropriate Scientific Review Group(s) convened by the NIMHD , in accordance with NIH peer
review policy and procedures, using the stated review
criteria. Review assignments will be shown in the eRA Commons.
As part of the scientific peer review, all applications:
Applications will compete for available funds with all other recommended applications submitted in response to this FOA. Following initial peer review, recommended applications will receive a second level of review by the National Advisory Council on Minority Health and Health Disparities. The following will be considered in making funding decisions:
After the peer review of the application is completed, the PD/PI will be able to access his or her Summary Statement (written critique) via the eRA Commons.
Information regarding the disposition of applications is available in the NIH Grants Policy Statement.
If the application is under consideration for funding, NIH
will request "just-in-time" information from the applicant as
described in the NIH Grants
Policy Statement.
A formal notification in the form of a Notice of Award (NoA) will be provided
to the applicant organization for successful applications. The NoA signed by
the grants management officer is the authorizing document and will be sent via
email to the grantee business official.
Awardees must comply with any funding restrictions described in Section IV.5. Funding Restrictions. Selection
of an application for award is not an authorization to begin performance. Any
costs incurred before receipt of the NoA are at the recipient's risk. These
costs may be reimbursed only to the extent considered allowable pre-award costs.
Any application awarded in response to this FOA will be subject to the DUNS,
CCR Registration, and Transparency Act requirements as noted on the Award
Conditions and Information for NIH Grants website.
All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Grantees, and Activities. More information is provided at Award Conditions and Information for NIH Grants.
The The following special terms of award are in addition to,
and not in lieu of, otherwise applicable U.S. Office of Management and Budget
(OMB) administrative guidelines, U.S. Department of Health and Human Services
(DHHS) grant administration regulations at 45 CFR Parts 74 and 92 (Part 92 is
applicable when State and local Governments are eligible to apply), and other
HHS, PHS, and NIH grant administration policies.
The administrative and funding instrument used for this program will be the
cooperative agreement, an "assistance" mechanism (rather than an
"acquisition" mechanism), in which substantial NIH programmatic
involvement with the awardees is anticipated during the performance of the
activities. Under the cooperative agreement, the NIH purpose is to support and
stimulate the recipients' activities by involvement in and otherwise working
jointly with the award recipients in a partnership role; it is not to assume
direction, prime responsibility, or a dominant role in the activities.
Consistent with this concept, the dominant role and prime responsibility
resides with the awardees for the project as a whole, although specific tasks
and activities may be shared among the awardees and the NIH as defined below.
The PD(s)/PI(s) will have the primary responsibility for:
NIH staff have substantial programmatic involvement that is above and beyond the normal stewardship role in awards, as described below:
Areas of Joint Responsibility include:
Dispute Resolution:
Any disagreements that may arise in scientific or programmatic matters (within the scope of the award) between award recipients and the NIH may be brought to Dispute Resolution. A Dispute Resolution Panel composed of three members will be convened. It will have three members: a designee of the Steering Committee chosen without NIH staff voting, one NIH designee, and a third designee with expertise in the relevant area who is chosen by the other two; in the case of individual disagreement, the first member may be chosen by the individual awardee. This special dispute resolution procedure does not alter the awardee's right to appeal an adverse action that is otherwise appealable in accordance with PHS regulation 42 CFR Part 50, Subpart D and DHHS regulation 45 CFR Part 16.
When multiple years are involved, awardees will be required to submit the Non-Competing Continuation Grant Progress Report (PHS 2590) annually and financial statements as required in the NIH Grants Policy Statement.
A final progress report, invention statement, and Financial Status Report are required when an award is relinquished when a recipient changes institutions or when an award is terminated.
The Federal Funding Accountability and Transparency Act of 2006 (Transparency Act), includes a requirement for awardees of Federal grants to report information about first-tier subawards and executive compensation under Federal assistance awards issued in FY2011 or later. All awardees of applicable NIH grants and cooperative agreements are required to report to the Federal Subaward Reporting System (FSRS) available at www.fsrs.gov on all subawards over $25,000. See the NIH Grants Policy Statement for additional information on this reporting requirement.
We encourage inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants.
GrantsInfo (Questions regarding application instructions and
process, finding NIH grant resources)
Telephone 301-710-0267
TTY 301-451-5936
Email: [email protected]
eRA Commons Help Desk(Questions regarding eRA Commons
registration, tracking application status, post submission issues)
Phone: 301-402-7469 or 866-504-9552 (Toll Free)
TTY: 301-451-5939
Email: [email protected]
Nathan Stinson, Jr., PhD, MD, MPH
Acting Director, Division of Extramural Activities and
Scientific Programs
National Institute on Minority Health & Health Disparities (NIMHD)
Telephone: (301) 594-8704
Email: [email protected]
Robert Nettey, MD
Chief, Office of Review
National Institute on Minority Health & Health Disparities (NIMHD)
Telephone: (301) 496-3996
Email: [email protected]
Priscilla Grant, JD, CRA
Chief Grants Management Officer
National Institute on Minority Health & Health Disparities (NIMHD)
Telephone: 301-594-8412
Email: [email protected]
Recently issued trans-NIH policy notices may affect your application submission. A full list of policy notices published by NIH is provided in the NIH Guide for Grants and Contracts. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Parts 74 and 92.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
| ||||||
|
|
|
Department of Health and Human Services (HHS) |
|
|||
|
NIH... Turning Discovery Into Health® |
||||||